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Abstract  
Background: 
Patellofemoral pain (PFP) is one of the most common forms of knee pain in adults under the age of 
40, with a prevalence of 23% in the general population. The long-term prognosis is poor, with only one 
third of people pain-free one year after diagnosis.  
The biomedical model of pain in relation to persistent PFP has recently been called into question. It 
has been suggested that interventions for chronic musculoskeletal conditions should consider 
alternative mechanisms of action, beyond muscles and joints. Modern treatment therapies should 
consider desensitizing strategies, with exercises that target movements and activities patients find 
fearful and painful. 
High quality research on exercise prescription in relation to pain mechanisms, not directed at specific 
tissue pathology, and dose response clearly warrants further investigation. 
Our primary aim is to establish the feasibility and acceptability of conducting a definitive RCT which 
will evaluate the clinical and cost-effectiveness of a loaded self-managed exercise programme for 
people with patellofemoral pain. 
 
Method: 
This is a single-centred, multiphase, sequential, mixed-methods trial that will evaluate the feasibility 
of running a definitive large scale randomised controlled trial of a loaded self-managed exercise 
programme versus usual physiotherapy. Initially 8 – 10 participants with a minimum 3-month history 
of PFP will be recruited from an NHS physiotherapy waiting list and interviewed. Participants will be 
invited to discuss perceived barriers and facilitators to exercise engagement, and the meaning and 
impact of PFP. Then, 60 participants will be recruited in the same manner for the main phase of the 
feasibility trial. A web-based service will randomise patients to a loaded self-managed exercise 
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programme or usual physiotherapy. The loaded self-managed exercise programme is aimed at 
addressing lower limb knee and hip weakness, and is positioned within a framework of reducing 
fear/avoidance with an emphasis on self-management. Baseline assessment will include demographic 
data, average pain within the last week (VAS), fear avoidance behaviours, catastrophising, self-
efficacy, sport and leisure activity participation, and general quality of life. Follow-up will be 3 and 6 
months. The analysis will focus on descriptive statistics and confidence intervals. The qualitative 
components will follow a thematic analysis approach.  
Discussion: 
This study will evaluate the feasibility of running a definitive large scale trial on patients with 
patellofemoral pain, within the NHS in the UK. We will identify strengths and weaknesses of the 
proposed protocol and the utility and characteristics of the outcome measures. The results from this 
study will inform the design of a multicentre trial. 
Trial registration: ISRCTN 35272486  
Keywords: Mixed methods study, feasibility, patellofemoral pain, anterior knee pain, exercise 
therapy 
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Background 
Patellofemoral pain (PFP) is one of the most common forms of knee pain in adults under the age of 40 
[1–3], with an estimated prevalence of 23% in the general population [1]. Typically, symptoms include 
retropatella pain, or diffuse peripatellar pain, aggravated by activities that load the joint, such as 
climbing and descending stairs, squatting and running [4].  
The overall long-term prognosis for the majority of patients with PFP is poor [5]. One third of patients 
are pain-free one year after the diagnosis [5]. Patients will typically withdraw from participation in 
sport and leisure activities [6, 7], and symptoms can continue for many years [5, 8]. Furthermore, 
many individuals with PFP develop associated psychological distress, such as fear-avoidance and 
catastrophising thoughts in relation to their knee pain [9–11]. It is such a common, yet poorly 
understood condition, that the Chartered Society of Physiotherapy, UK (CSP) has ranked PFP the 3rd 
most important topic out of 185 in their Musculoskeletal Research Priority Project in 2012 [12]. 
There remains scientific debate and uncertainty around the underlying aetiology of the condition [13], 
and it is thought most likely to be multifactorial in its origin [14]. There is currently little high quality 
level 1 evidence on which to base conservative management [15]. Historically, models of clinical 
reasoning based on the patho-anatomical basis of tissue pathology and differential diagnosis have 
labelled one major cause of PFP as patellar mal-tracking/malalignment [14, 16–18], with the 
supposition that various tissue structures could be contributing, such as: general muscle weakness 
[19], soft tissue tightness [20], lower limb structural abnormalities [21], movement dysfunction [22] 
and quadriceps mal-timing [23]. It is thought that these deviations from the ‘normal’ affect patellar 
alignment, kinematics or joint loading, resulting in greater stress between the patella and femur and 
the development of pain and dysfunction [14, 16–18]. This biomedical model of pain establishes a 
direct relationship between tissue structure and pain [24], and traditionally the focus of physiotherapy 
treatment has been aimed at reducing pain and improving function by addressing these biomedical 
tissue structures; treatments include taping, stretches, exercises, electrotherapy, joint mobilisations 
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and foot orthoses have all been suggested [16, 17]. However, systematic reviews consistently 
acknowledge the limitations of included studies when drawing their conclusions on the effectiveness 
of these interventions [14, 15, 17, 25–27]. Even in relation to exercise therapy, which has the strongest 
evidence-base [15], there remains insufficient evidence on which to determine the best form and dose 
of exercise [25].   
Exercise therapy designed to load and temporarily aggravate patients’ symptoms has shown to be 
beneficial for tendon pain [28], shoulder pain [29–31], low back pain [32, 33] and plantar heel pain 
[34]. In agreement with Nijs et al. [35],  Littlewood et al [36] hypothesised that the positive response 
to the painful loaded exercise programme could be attributed to the therapeutic impact upon the 
central nervous system. Specifically, the exercise prescribed is aimed at addressing fear avoidance and 
catastrophising beliefs within a framework of ‘hurt not equalling harm’, with pain rationalised as ‘de-
conditioned’ tissue. Thus, in time, reducing the overall sensitivity of the central nervous system, with 
a modified pain output.  
Exercise interventions for PFP have shown a ‘dose response’; characteristically, the more exercise the 
patient does the better their pain and functional improvement in the long term. A study in Norway 
(n=42) looked at a high dose regime versus a low dose regime, and concluded that there was 
significant benefit in the high dose group over low dose in terms of pain and function at 12 weeks [37]. 
Strikingly, the one year follow-up showed that the high dose group had continued to improve in terms 
of pain and function, while the low dose group had deteriorated [37, 38]. This finding is supported by 
a more recent study looking at supervised exercises and education versus education alone [39]. In this 
study 121 adolescents were randomised into the two groups, with exercise adherence monitored 
through attendance and weekly text messages. They demonstrated that successful outcome (defined 
as ‘completely recovered or strongly improved’ on a seven-point Likert scale) was directly correlated 
to the amount of exercise a patient did; if they completed the exercises 0 – 1 x a week 21% recovered 
compared with 55% who completed the exercises three or more times a week. A recent systematic 
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review and meta-analysis of painful exercises versus pain free exercises for chronic MSK pain found 
protocols using painful exercises offered a small, but significant benefit over pain-free exercises in the 
short term; and that protocols using painful exercises typically have higher loads and dose of exercise 
[40]. The optimal dose of exercise for the greatest improvements in PFP is still unknown [25] and 
warrants further investigation in relation to load and resistance.  
High quality research on exercise prescription in relation to pain mechanisms and dose response (or 
response to load/resistance) clearly warrants further investigation, particularly when considering the 
current paucity of high quality evidence on which to determine the best form of exercise intervention 
for PFP. 
Purpose  
The primary aim is to establish the feasibility and acceptability of conducting a definitive RCT which 
will evaluate the clinical and cost-effectiveness of a loaded self-managed exercise programme for 
people with patellofemoral pain compared to usual physiotherapy.  
Secondary aims include establishing: if the devised loaded self-managed exercise programme can be 
delivered as planned in an NHS physiotherapy outpatient clinic; if the outcome measures are feasible 
to use within an NHS setting; if reliable data can be collected; a sample size calculation for an RCT; if 
the intervention is acceptable and tolerable to participants and physiotherapists; if it is feasible to 
recruit and randomise participants; the potential barriers to recruitment and the training package 
delivered to physiotherapists.  
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Methods 
Study Design 
This is a single-centred, multiphase, sequential, mixed-methods trial. It incorporates an initial 
qualitative component; followed by a feasibility randomised controlled trial (RCT); with a final 
qualitative component. Reporting of this protocol will follow the SPIRIT statement [41].  
Phase 1 will recruit 8 to 10 participants and individual interviews will be performed with the purpose 
of understanding the impact of PFP with their lives. Their physiotherapy will continue as normal.   
Phase 2:  A clinical trial will then be conducted with 60 further participants (recruited separately to 
phase 1). These participants will be randomised to the intervention group or to the control group.  
Phase 3: A sub group of participants (8 to 10) from phase 2, along with a sub-group of the 
physiotherapists involved in phase 2 (8 –10), will be asked to take part in individual interviews that 
will explore the acceptability and feasibility of study design parameters and the intervention from 
phase 2.  
Recruitment  
Selection of trial participants for phase 1 and phase 2 will follow the same procedure. Potential trial 
participants will be identified and triaged from the NHS physiotherapy waiting list at Derby Teaching 
Hospitals NHS Foundation Trust by the usual department physiotherapists who perform referral 
triage. Patients are referred from general practitioners and from orthopaedics and rheumatology 
hospital departments. An introductory letter accompanied by an information sheet and consent form 
will be sent out to potential trial participants by a member of the clinical team. This will be followed 
up by a telephone call from a member of the clinical team offering further information and enquiring 
about participation. Patients showing an initial interest will be asked questions to check they match 
the inclusion criteria and interview/assessments will be booked with the research team.  
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Eligibility Criteria 
Based on a consensus gained from previous systematic reviews and studies [14, 39] the participants 
will be recruited from the waiting list according to the following criteria: men and women aged 18 to 
40 who are able to give written informed consent; a clinical diagnosis of unilateral or bilateral PFP of 
greater than three months duration (if bilateral the worst knee will be investigated); anterior or 
retropatellar pain reported on at least two of the following activities: prolonged sitting, ascending or 
descending stairs, squatting, jumping and running.  
Exclusion criteria include: previous knee surgery; awaiting lower limb surgery; knee ligamentous 
instability; history of patellar dislocation; true knee locking or giving way; reasons to suspect systemic 
pathology, or acute illness; pregnancy or breast feeding; patellar or iliotibial tract tendinopathy; and 
not able to speak or understand English.  
 
Interventions  
Phase 1 – Interviews  
Interview participants will explore perceived barriers and facilitators to exercise engagement, the 
meaning to the participant and impact of having PFP. This may be used to tailor the intervention in 
phase 2 and to inform the phase 3 interviews, if appropriate.  
A convenience sample of the first 10 participants recruited will be invited to discuss factors 
surrounding the meaning and lived experience of PFP. The interviews will occur in the participant’s 
home or another suitable venue of their choice. There will be an interview schedule to guide (but not 
lead) discussion.  
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Phase 2 – Pilot Clinical Trial  
Exercise Intervention 
The ‘experimental’ intervention is a loaded self-managed exercise programme for the knee and hip, 
aimed at addressing lower limb knee and hip weakness [25]. It is set within a framework of reducing 
fear/avoidance and with an emphasis on self-management and reducing the need for direct 
physiotherapy intervention.  
 
Before any prescription of exercise, the physiotherapist will spend a period of time educating the 
participant about pain mechanisms. Descriptions of tissue based pathology models of pain, e.g. 
patellar mal-tracking, or limb mal-alignment will be actively discouraged and challenged by the 
physiotherapist. The participant will gain an evidenced-based understanding of dysfunctional central 
nociceptive processing as an explanation of chronic and persistent pain [42], and the role and impact 
of fear [43]. This period of intense learning is designed to facilitate the reconceptualisation of pain, 
with an emphasis on descriptions of pain neuroscience rather than psychology [44], and from the 
perspective and context of the participant and their pain [45]. The education regarding pain 
mechanisms will take up a large portion of clinical time, such as to address any beliefs or fear within 
the participant that pain is a sign of tissue damage, and will be delivered in a Socratic teaching style 
[46]. It is expected that the education period will be complete in the first session, which typically lasts 
30 – 40 minutes within the NHS, but participants that require further re-assurance may continue into 
their second session. 
 
The exercise will be prescribed by the physiotherapist and will typically involve body weight resistance 
in the form of a modification of the ‘Step Down’ function test [47]; a single leg squatting exercise 
sideways on a step. By performing sideways, the participant will be able to use the guide of the wall 
and/or banister more easily, as guided by our patient and public involvement feedback. The exercise 
requires balance, knee extension strength, eccentric control and isometric hip strength.  The 
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participant will be advised to exercise to the point of fatigue, such that it reproduces their pain and 
discomfort, but ensuring the pain is manageable [48–50].  
 
Exercise progression is guided by symptomatic response, such that the participant is advised that on 
cessation of the exercise the pain should remain no worse than pre-exercise [48]. Participants with 
more severe pain will start on a lighter regime, and this will be guided by the baseline functional 
assessment by the treating physiotherapist. Participants will be advised to exercise at a level they find 
acceptable and tolerable. Participants are able to start exercising, if they wish, at a very low level, with 
little or no short-term pain increase, and progress when they feel comfortable and confident. 
Regression will be in the form of reduced repetitions, or lightening the exercise, for example to double 
leg squats 0-30° knee flexion.  Progression can be in the form of increased repetitions or increasing 
the load by moving to plyometric exercises, such as jumping and hopping, for younger participants 
with higher sporting requirements. The physiotherapist will plan the exercise, motivate and review 
participant’s physical performance and expectations [35].  
 
A single exercise approach will be used for this intervention. Poor levels of exercise adherence are well 
documented [51], and it has been suggested that a single exercise represents a pragmatic time saving 
approach [52]. Additionally, as previously discussed, the optimal dosage of an exercise prescription is 
unknown, and a single exercise approach may allow better monitoring of dosage and adherence. 
Importantly, it will enable the participant to observe others (the physiotherapist) perform the task 
successfully, and facilitate the development of mastery of the task. This combined with specific verbal 
and social persuasion from the physiotherapist, will further promote reconceptualisation of the pain, 
specific to the participant and their context; all thought to be key modifiers of perceived self-efficacy 
[53].  
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The participants will be advised that the exercise should be performed twice a day. The participant 
will be encouraged to self-direct in progressing/regressing the repetitions, as guided by their pain 
response, thus further internalising the locus of control and moving towards self-management [53].   
 
Goal setting will be a central part of the intervention. The reconceptualisation of pain through the 
exercise intervention leads onto the reconceptualization of pain in the participant’s daily activities, 
including sport and leisure activity, and setting goals helps this transition.  
 
Other self-management strategies employed will be the discussion about managing ‘flare ups’ and 
potential or perceived barriers to successful outcomes [35, 52]. This will be through a thorough 
questioning and discussion with the physiotherapist and participant. Questions such as: Is this safe for 
your knee? Is exercise good for you? Are you confident of completing this exercise? What do you think 
will happen? Why do you think that? It is thought that a discussion based on this approach will reveal 
the participant’s perception of exercise, and potential barriers and fears [35].  
 
Keeping the treatment pragmatic, timing over follow-ups, the number of treatment sessions, 
frequency and discharge, physiotherapy concomitant treatments will be at the discretion of the 
qualified physiotherapist, but with the aim of the programme being self-management, self-directed 
exercise and discouraging concomitant treatments. The mean number of sessions for physiotherapy 
treatment of PFP is eight [54], and the prediction is that self-management strategies should lower the 
expected number of treatment sessions for the intervention group to three to five sessions.  The 
timings of the follow-up appointments are also pragmatic in nature, and at the discretion of the 
physiotherapist in discussion with the participant. Following the problem solving and barrier 
discussion the physiotherapist will have understanding of the participant’s ongoing perception of their 
pain. Those that require further re-assurance may return sooner, one to three weeks; and those that 
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are comfortable to self-manage sooner will return after a longer period of time, four to six weeks, or 
not at all in some cases.  All participants have the opportunity to telephone for support if required.  
 
To avoid cross-contamination between the two groups, the delivered intervention group will be 
treated by different qualified physiotherapists, who will be excluded from treating participants from 
the comparator group. Furthermore, physiotherapists treating ‘usual physiotherapy’ will not receive 
the intervention training package. The intervention training package will be delivered to the treating 
physiotherapists by the research team. The training package will consist of 2 x 2 hour sessions, 
scheduled to fit into the usual in-service training slots.   
The comparator 
Usual physiotherapy typically involves strengthening exercises [55–57], taping [17, 58], stretches [59], 
and foot orthoses [60], and these are often aimed at restoring the assumed patella malalignment [16, 
17]. The comparator will be usual physiotherapy as directed by the normal assessment and clinical 
decision-making by the treating physiotherapist. Details about the nature of the treatments will be 
collected.   
Phase 3 – Interviews 
Potential interviewees will be purposively sampled from the phase 2 RCT with initial contact made via 
telephone to ask whether they would be willing to participate (information sheet and consent form 
for phase 2 and 3 are combined).  A sample of eight to ten participants will be required with a sample 
of responders and non-responders, from both intervention arm and comparator group, with 1:2 
proportion of males to females to reflect gendered differences in prevalence [1]. Participants lost to 
follow-up will be telephoned and encouraged to take part.  This process will begin 6 months after 
randomisation. If the participant agrees, a convenient time will be arranged to complete an interview 
at the participant’s home or physiotherapy clinic. Consent for the phase 2 clinical trial will include 
consent for participation in phase 3.   
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Treating physiotherapists will be invited to take part in interviews. A purposive sample of eight to ten 
will be required, with a mixture representing both the intervention group and comparator group, with 
different grades and length of clinical experience. Consent for this will be taken separately.  
The emphasis within the intervention arm is towards self-management and exercises that are 
performed with pain. Therefore the aim of the qualitative investigation is to give an insight into the 
participants’ and physiotherapists’ perceptions and experiences of the process. There have been 
recent developments on our understanding of the impact of patients’ and therapists’ attitudes and 
beliefs on pain [61],  therefore these factors are extremely important to understand. Also, study design 
parameters will be discussed to explore recruitment and randomisation in this participant group. All 
interviews will be face-to-face at a location and time convenient to the interviewee. Interviews will be 
semi-structured and will broadly consider the acceptability and practicality of the exercise 
programme. For participants, data collection will consider: views on the nature and form of the 
exercise; perception of its benefits, difficulties and barriers, and perceptions of study design i.e. 
recruitment, consent, data collection and follow-up periods. For physiotherapists, data collection will 
consider: views on the nature and form of the exercise; perception of its benefits, difficulties and 
barriers; views on the delivery of the training package.  The interviews will be guided by a semi-
structured schedule.  
Outcome Assessments  
Our patient and public involvement representative has reviewed and approved the outcome 
assessments, and has a total estimated completion time of 10 – 15 minutes. The schedule for 
assessments is found in the SPIRIT figure (Table 1). 
Baseline demographic data will include; age, sex and duration of symptoms. The primary outcome 
measure that we will test the feasibility of will be a global rating of change at follow-up, the proportion 
of participants who have recovered (defined as ‘completely recovered’ or ‘strongly recovered’), 
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measured on a 7-point Likert scale ranging from “completely recovered” to “worse than ever” [39, 57, 
62]. 
Secondary outcome measures that we will test the feasibility of using will include:  visual analogue 
scale (VAS) for pain, kinesiophobia, catastrophizing, self-efficacy, sport participation and the generic 
health outcome Euro-QOL (EQ-5D-5L).   
Average pain within the last week  will be measured on the visual analogue scale (VAS) 0 to 10 cm 
[63]; 0 represents no pain, 10 the worst pain possible; this scale has been shown to be valid for PFP 
with a minimal clinically important difference (MCID) of 2 [64].  
Fear associated with avoidance behaviours and kinesiophobia will be measured with the Tampa Scale 
for Kinesiophobia (TSK) [9, 65]. This is a 17 item questionnaire widely used for the assessment of fear 
of movement and been shown to be reliable and valid for an English speaking population with spinal 
pain. Each question is scored on a 4-point Likert scale ranging from ‘strongly disagree’ (1) to strongly 
agree (4), giving a total possible score of 17 to 68.  
 
Catastrophizing will be measured by means of the ‘Pain Catastrophizing Scale’ (PCS) [66]. The PCS scale 
is a 13 item questionnaire used to explore participants’ thoughts and feelings when experiencing pain. 
Each question asks the degree with which the participant agrees with the statement, and is scored on 
a 5-point Likert scale ranging from ‘not at all’ (0) to ‘all the time’ (4), giving a total possible score of 0 
to 52.  
Self-efficacy has shown to be a strong predictor of disability in patients with MSK pain [67], therefore 
the General Self Efficacy Scale will also be used (GSES) [68]. The GSES is a 10 item questionnaire with 
each question asking the degree with which the participant agrees with the statement, with a 4-point 
Likert scoring structure ranging from ‘not at all’ (1) to ‘exactly true’ (4). The questions are used to 
explore the participants’ perceived belief at coping with a range of stressful and challenging demands; 
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with a total possible score of 10 to 40. The GSES has been shown to have high reliability and validity 
across multiple languages and settings [69].  
Patients characteristically withdraw from participation in sport and leisure activities [6], therefore the 
number of times the participant has participated in leisure time sport or exercises within a week will 
be recorded. 
The generic Euro-QOL (EQ-5D-5L) is a generic health outcome used widely internationally [70]. The 
questionnaire has 5 questions about mobility; usual activities; self-care; pain and discomfort; and 
anxiety and depression. The results are converted into in single summary index and can be used to aid 
and assist any future economic evaluation planned for the definitive RCT.  
Compliance is the act of conforming and following the prescribed dosage, timing and frequency of the 
exercise. Feasibility outcomes of compliance levels will be monitored through a participant activity 
diary. Participants will be asked to complete an exercise diary daily for 6 months indicated how many 
repetitions they completed of their exercise.  
Non-responders will be telephoned after seven days to encourage them to complete the forms and 
return them. 
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 STUDY PERIOD 
 Enrolment Allocation 
Post-allocation Close-out 
TIMEPOINT** 
October 
2016 – May 
2017 
October 
2016 – May 
2017 
Month 
1 
Month 
2 
Month 
3 
Month 
4 
Month 
5 
Month 
6 
May 2017 – 
August 
2018 
ENROLMENT: 
     
 
   
Eligibility screen X     
 
   
Informed consent  X     
 
   
Allocation  X    
 
   
INTERVENTIONS:      
 
   
Loaded Self-
Managed 
     
 
   
Usual 
Physiotherapy 
     
 
   
ASSESSMENTS:      
 
   
Diagnosis  X    
 
   
Baseline 
demographic 
 X    
 
   
Seven-point Likert 
scale 
    X 
 
 X  
Pain VAS 
(previous week’s 
average) 
 X   X 
 
 X  
Tampa Scale for 
Kinesiophobia 
 X   X 
 
 X  
Pain 
Catastrophizing 
Scale 
 X   X 
 
 X  
General Self 
Efficacy Scale 
 X   X 
 
 X  
Number of leisure 
sport and exercise 
in previous week 
 X   X 
 
 X  
Euro-QOL (EQ-5D-
5L) 
 X   X 
 
 X  
Submission of 
Exercise Diary 
     
 
 X  
Table 1 - SPIRIT figure. Schedule of enrolment, interventions and assessments 
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Sample size 
A formal sample size calculation will not be performed since this is a feasibility study. We therefore 
envisage being able to recruit 30 participants into each treatment arm, and we consider that this will 
give a robust and useful amount of information [71]. Part of the feasibility study is to investigate the 
feasibility of recruitment. However, we envisage recruiting 60 participants in 13 months.  
 
We will use the primary outcome measure, the global rating of change scale, to inform a sample size 
calculation for a definitive RCT.  
 
Randomisation  
Patients who fulfil the inclusion and exclusion criteria, read and understood the patient information 
sheet and have given written consent to take part in the trial will be randomised to either the 
intervention or the control. A web-based randomisation service with secure password protected login 
using random variable block-size will be used.  
Due to the nature of therapeutic studies, blinding of the participants and physiotherapists is not 
possible [72]. 
 
Data Collection Methods 
Phase 1 & 3 
Interviews will be recorded with a digital recorder.  The interviews will then be transcribed verbatim 
and analysed.  
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Phase 2 
Baseline data will be captured prior to randomisation in the physiotherapy clinic. Follow-up 
assessments will be 3 months and 6 months (by post with a stamped addressed envelope for return). 
Participants will be asked to post back their exercises diary at the 6 month follow-up. 
Planned data analysis 
Phase 1 & 3 
The qualitative components will follow a thematic analysis approach, as described by Braun and Clarke 
(2006) [73]. Line by line coding, leading to a thematic analysis (using an abductive research strategy), 
will be used. Following data familiarisation, initial codes will be generated and peer reviewed, by a 
member of the research group, to search for common themes. This will be carried out using the NVivo 
software (NVivo qualitative data analysis Software; QSR International Pty Ltd. Version 11, 2015). For 
phase 1 the analysis will assess the lived experience of PFP; for phase 3 the analysis will broadly assess 
acceptability and feasibility of study design, intervention and training package to physiotherapists. 
 
Phase 2 
The analysis will focus on descriptive statistics and confidence intervals for the variables we are 
obtaining. The characteristics of the participants will also be described using means, standard 
deviations and ranges for quantitative variables and counts and proportions for categorical variables. 
As this is a feasibility study we are testing our ability to collect data, therefore no data imputation will 
be performed to account for any missing data. 
Feasibility threshold will be set at 75% for recruitment. Feasibility threshold will be set at 75% to assess 
reliability and completeness of outcome measures. Data relating to timing of the return of outcome 
forms, department referral rate, recruitment rate and numbers lost to follow-up will be recorded. 
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Acceptability and tolerability of the treatment intervention will be assessed through completeness of 
outcome measures, and feedback from the phase 3 qualitative interviews.  
Monitoring 
 
The exercise intervention is low risk, and is commonly used in the population. The occurrence of an 
adverse event as a result of participation within this study is not expected and no adverse event data 
will be collected.  
 
Access to the final trial data set 
All available data can be obtained by contacting the corresponding author. 
Patient and Public Involvement 
This research project has been driven by the views of people suffering from patellofemoral pain (PFP). 
Patients who receive physiotherapy for PFP have been consulted for their views, including patient 
members of the Steering Group Committee. Thoughts and preferences to current programmes of 
therapy and treatment have been requested, and these views have been incorporated into the 
planning, design, application and dissemination of this study.  
Patients stressed the importance of ensuring minimal number of exercises for improved adherence; 
the tailoring of the physiotherapy intervention around their usual sport/hobbies (where appropriate); 
and the capability of telephone support when required at short notice.  
The main exercise of the intervention itself was adapted after consultation with patients. Initially the 
intervention was an exercise based upon the ‘Step Down’ function test [47]. The feedback from the 
patients was that performing the same manoeuvre sideways, rather than facing down the step, 
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allowed them to use the guide of the wall and/or banister with their hands.  This has been 
incorporated into the intervention.  
 
Discussion 
We have presented the rationale and design of a mixed-methods feasibility study for a loaded self-
managed exercise programme for PFP. The premise that a loaded self-managed lower limb 
strengthening exercise, that is not directed at specific tissue pathology, but rather based on the 
neurophysiology of pain, set within clearly defined boundaries, will have a positive impact upon fear-
avoidance, catastrophizing and self-efficacy behaviour and patient reported pain levels. The feasibility 
of a large definitive RCT will either be established, or negated, and the results of the trial will be 
published when they are available.  
List of abbreviations  
CKRS  Cincinnati knee rating system 
CSP  Chartered Society of Physiotherapy, UK  
EQ-5D-5L Euro-QOL 
GSES  General self-efficacy scale 
HEE   Health Education England 
MCID  Minimal clinically important difference 
MRI  Magnetic Resonance Imaging 
MSK  Musculoskeletal  
NHS  National Health Service  
NIHR  National Institute for Health Research 
PCS  Pain catastrophizing scale 
PFP  Patellofemoral pain  
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RCT  Randomised controlled trial 
TSK  Tampa Scale for Kinesiophobia 
VAS  Visual analogue scale  
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